GENPHARMASEC
Back to Balance Sheet
|
GENPHARMASEC Last 5 Year Total Current Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | |
|---|---|---|---|
| Total Current Liabilities | ₹9.84 Cr | ₹2.70 Cr | ₹2.06 Cr |
What is the latest Total Current Liabilities ratio of GENPHARMASEC ?
| Year | Total Current Liabilities |
|---|---|
| Mar2025 | ₹9.84 Cr |
| Mar2024 | ₹2.70 Cr |
| Mar2023 | ₹2.06 Cr |
How is Total Current Liabilities of GENPHARMASEC Trending?
| Years | Total Current Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹9.84 Cr | 264.03 | |
| Mar2024 | ₹2.70 Cr | 30.91 | |
| Mar2023 | ₹2.06 Cr | - | |
Compare Total Current Liabilities of peers of GENPHARMASEC
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| GENPHARMASEC | ₹62.6 Cr | -7.4% | 0.9% | -41.2% | Stock Analytics | |
| SUDARSHAN CHEMICAL INDUSTRIES | ₹6,312.9 Cr | 4.1% | -5.3% | -18.8% | Stock Analytics | |
| KIRI INDUSTRIES | ₹2,615.8 Cr | 6.1% | 0.2% | -32.3% | Stock Analytics | |
| VIDHI SPECIALTY FOOD INGREDIENTS | ₹1,613.2 Cr | -0.6% | 8.1% | -25.2% | Stock Analytics | |
| SHREE PUSHKAR CHEMICALS & FERTILISERS | ₹1,088.0 Cr | 0.5% | 5.7% | 34.9% | Stock Analytics | |
| BODAL CHEMICALS | ₹840.6 Cr | 3.8% | 50.7% | 3% | Stock Analytics | |
GENPHARMASEC Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| GENPHARMASEC | -7.4% |
0.9% |
-41.2% |
| SENSEX | 3.7% |
-0.9% |
0.7% |
You may also like the below Video Courses